BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4323415)

  • 1. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
    Zbar B; Bernstein ID; Bartlett GL; Hanna MG; Rapp HJ
    J Natl Cancer Inst; 1972 Jul; 49(1):119-30. PubMed ID: 4338767
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 5. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 6. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG; Bast RC; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
    Snodgrass MJ; Hanna MG
    Cancer Res; 1973 Apr; 33(4):701-16. PubMed ID: 4348772
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG).
    Zbar B; Hunter JT; Rapp HJ; Canti GF
    J Natl Cancer Inst; 1978 May; 60(5):1163-8. PubMed ID: 642033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of established oral tumors after intralesional injection of living BCG or BCG cell walls.
    Zbar B; Canti G; Rapp HJ; Bier J; Borsos T
    Cancer; 1979 Apr; 43(4):1304-7. PubMed ID: 376088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Zbar B; Bernstein I; Tanaka T; Rapp HJ
    Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.
    Hanna MG; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 May; 48(5):1441-55. PubMed ID: 4337912
    [No Abstract]   [Full Text] [Related]  

  • 15. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.
    Hanna MG; Peters LC
    Cancer; 1975 Oct; 36(4):1298-304. PubMed ID: 1175128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally active.
    Zbar B; Ribi E; Rapp HJ
    Cancer; 1977 Dec; 40(6):2930-2. PubMed ID: 201359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center.
    Zbar B; Minden P; McClatchy JK; Rapp HJ
    J Natl Cancer Inst; 1976 Feb; 56(2):443-4. PubMed ID: 176390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of cryosurgical treatment of experimental intradermal tumors to eradicate microscopic lymph node metastases in guinea pigs.
    Javadpour N; Bagley DH; Zbar B
    J Natl Cancer Inst; 1979 Jun; 62(6):1479-81. PubMed ID: 286120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.